Lüdemann, Jörg
2 papers on CoChat
Most cited papers
- Verified
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial
Pratley, R. E., Aroda, V. R., Lingvay, I., Lüdemann, J., Andreassen, C., Navarria, A., & Viljoen, A. (2018) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 790
- Verified
A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin
Violante, R., Oliveira, J. H. A., Yoon, K. ‐., Reed, V. A., Yu, M. B., Bachmann, O. P., Lüdemann, J., & Chan, J. Y. C. (2012) · Diabetic Medicine
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free